Extremely important positive changes in investment behavior have recently occurred for Anixa Biosciences Inc (NASDAQ: ANIX): its shorter term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside volume developed, and the stock rose on very heavy volume.
In light of these very positive signals we are reviewing our current Overall Rating of F. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
ANIX’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Anixa Biosciences has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Anixa Biosciences has a poor Power Rating of 25 and a very low Appreciation Score of 7, resulting in the Lowest Value Trend Rating.
Recent Price Action
On 12/5/23, Anixa Biosciences Inc (NASDAQ: ANIX) stock increased 1.6%, closing at $3.75. Moreover, this advance was accompanied by exceptionally high trading volume at 651% of normal. The stock has been weak relative to the market over the last nine months but has risen 21.0% during the last week.
Be the first to comment